Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.
Watch this video where our Head of Human Pharmacology Unit (HPU), Dr. Anil talks about his journey & how Syngene can support clinical R&D programs & enables clients to fulfill their regulatory requirements.
Watch this video on Sarah Chatterjee, who recently completed 20 years in Syngene. She talks about her journey from trainee scientist to sales manager, Syngene’s growth from a single lab to three campuses spread across different locations, and more.
Watch this video where our Research Director, Dr. Santosh Kulkarni explains how Syngene delivers Chemistry services for drug discovery programs using cutting-edge science.
Watch this video on ‘Life at Syngene’ where we speak to Chetan Tamhankar, Head, Clinical Development services on Syngene capabilities in this space, the value we bring to our clients, future plans, and more.
Learn from our Head of bioanalytical Lab, Aparna Kasinath, how the field of biotherapeutics has evolved over the past decade, interesting projects at Syngene, and what makes Syngene so unique as a CRO/CDMO
Watch this video on what our Research Director, Jayadeva Sajankila, has to say on what makes Syngene unique, new expectations driving drug development today, and more.
Watch this video on what our Head of DMPK services Dr. Vishwottam Kandikere, has to say on what sets Syngene apart, emerging trends in DMPK, our current projects related to new modalities, and more.
In continuation of our earlier video on ‘Life at Syngene,’ learn from our Research Director, Jayadeva Sajankila, Syngene’s unique capabilities in Solid-state chemistry and how Safety is at the heart of everything we do – personally and professionally.
In continuation with our earlier video on Stability Studies, listen to our colleague and senior scientist, Sameer Bhide speak about why Syngene is the preferred partner for ICH Stability Studies for global biopharma companies